Weight management on the NHS is available, and for many patients it remains an excellent option. But it is not accessible to everyone, and for those who do qualify, waiting times have become a significant barrier. As NHS weight management lists grow longer and the demand for prescription weight loss treatment continues to rise, a growing number of people are exploring private alternatives, both legitimate and, increasingly, unregulated ones that carry serious clinical risk.
Understanding the difference between these routes, what each one offers, and how to make the right choice for your circumstances is more important now than at any point in the recent history of weight loss treatment in the UK. This guide sets out the facts without the sales pitch, so you can decide what is genuinely right for you.
Get in touch with our prescribing team, or complete our free online consultation to find out which weight loss treatment is right for you.
Quick Summary
NHS weight management services offer structured, multidisciplinary support but come with strict eligibility criteria and significant waiting times in most regions. Legitimate private online pharmacies offer faster access to the same licensed medications, without a GP referral, following a clinical consultation. A third route, purchasing through unregulated channels, is illegal, clinically dangerous, and responsible for a growing number of UK hospitalisations.
The NHS provides a range of weight management services across England, Scotland, Wales, and Northern Ireland, though provision varies considerably by region. At the community level, patients may be referred to NHS Tier 2 or Tier 3 weight management services, which typically include:
The NHS weight management pathway, when patients can access it, is comprehensive. It addresses not only the biological drivers of obesity but also the psychological and behavioural factors, and it does so without direct cost to the patient. For patients who meet the eligibility criteria and can access services in their area, it is a genuinely strong option.
The challenge, for a large proportion of patients, is getting there.
NHS weight management services are under considerable pressure. Demand has increased significantly following the licensing of GLP-1 medications for weight management, and many regions do not have the clinical infrastructure to absorb that demand within reasonable timeframes. In practice, this means:
None of this reflects poorly on the NHS as an institution. It reflects the scale of the clinical need relative to the current capacity. But for patients who are ready to begin treatment now, or who fall just outside the eligibility thresholds for specialist services, the NHS pathway may not be a practical option in the short term.
The private online pharmacy market for weight loss medication is large, legitimate in many cases, and regulated by the General Pharmaceutical Council (GPhC). A registered online pharmacy must display the EU common logo on its website, linking directly to the GPhC register where its registration can be verified. Treatment can only be dispensed following a proper clinical consultation conducted by a qualified independent prescriber.
When choosing a private online pharmacy, the following are non-negotiable indicators of a legitimate, safe provider:
If any of these elements are absent, the service should not be used. A pharmacy that dispenses prescription medication without a consultation, or that cannot demonstrate GPhC registration, is operating outside UK regulatory requirements regardless of how professional its website appears.
As NHS waiting lists have grown and the cost of private prescriptions has become a barrier for some patients, a third route has emerged. People are turning to online sources outside the regulated pharmaceutical system, including social media platforms, messaging apps, and informal sellers, to source weight loss medication without a prescription or clinical oversight.
The scale of this problem in the UK is now significant and well-documented. Approximately 18,300 illegal or unregulated weight loss and diabetes medications were seized entering the UK between 2024 and mid-2025. An ITV News investigation linked counterfeit “skinny jabs” to several UK hospitalisations, including at least one patient requiring intensive care treatment.
These are not isolated incidents. They are the foreseeable consequence of a market in which demand substantially outpaces regulated supply, and in which patients under financial or time pressure are being actively targeted by criminal sellers.
Clinical Safety Warning
We are urging anyone who is offered weight loss medication through an unregulated channel to make the police aware. This practice is illegal and highly dangerous. Unregulated products may contain unknown ingredients or incorrect doses, and there is no guarantee of what they are made from, where they originated, or whether the dose stated on the packaging is the dose actually present in the product.
For injectable products, there is the additional risk that needles and auto-injectors have not been properly sterilised, carrying a risk of serious infection. A pharmacy professional will assess which dose is appropriate for you based on your clinical history. An unregulated seller has no such knowledge, no such accountability, and no legal right to supply prescription medication.
This extends to weight loss medication tablets currently available in the United States but not approved for use in the UK market. These products have not been assessed by the MHRA, are completely unregulated in the UK, and are being sold through informal channels including Snapchat and other social media platforms. The fact that a product exists and is approved in another market does not make it safe or legal to supply or purchase in the UK outside a licensed pharmacy.
If you are offered weight loss medication through any channel that does not involve a GPhC-registered pharmacy and a formal prescription, decline it and report it. Contact Action Fraud, your local police, or the MHRA’s Yellow Card reporting scheme.
The right answer depends on your clinical circumstances, your location, your timeline, and your financial situation. Here is a straightforward framework for thinking it through:
Specific questions about accessing weight management services in the UK.
Currently, NHS prescribing of Mounjaro and Wegovy for weight management is being delivered through specialist NHS weight management clinics rather than through standard GP prescribing. This means a specialist referral is required, and access is subject to the phased rollout criteria set by NHS England. Some ICBs have begun broader rollout, but provision remains inconsistent nationally. Your GP can advise on local availability and referral pathways.
Responsible private prescribers will encourage patients to inform their GP that they are receiving prescription weight loss treatment, particularly if they have existing health conditions or take other medications. While there is no automatic notification from a private pharmacy to your GP surgery, sharing this information is clinically advisable to avoid potential interactions and ensure your overall care is coordinated. You can request a summary letter from your prescriber to share with your GP if helpful.
No. Accessing private treatment does not remove your right to NHS services or alter your clinical eligibility for NHS weight management support. If you subsequently meet the criteria for an NHS referral and wish to transition your care, this is a conversation to have with your GP. Your clinical history from private treatment, including your response to medication and any dose adjustments, may in fact be useful information for an NHS prescriber.
Yes. A GPhC-registered private pharmacy dispenses exactly the same licensed, MHRA-approved medications as an NHS prescription. The active compound, dose, manufacturer, and regulatory standards are identical. The difference is that the cost is borne by the patient rather than the NHS, and access does not require a GP referral or specialist waiting list. What is not the same is any product obtained outside a registered pharmacy, which may be counterfeit, contaminated, or entirely different from what it claims to be.
NHS eligibility thresholds do vary by integrated care board. As a general framework, Tier 2 lifestyle services are typically available from a BMI of 30 or above. NHS prescribing of GLP-1 medications through specialist clinics currently requires a BMI of 35 or above with at least one weight-related comorbidity – such as type 2 diabetes, hypertension, or obstructive sleep apnoea – though lower thresholds apply for patients from certain high-risk ethnic backgrounds. Criteria are subject to ongoing revision as the rollout expands. Some ICBs have historically applied local criteria above the national guidance, though NHS England’s national rollout framework is intended to standardise access over time. Always confirm current local eligibility with your GP.
The seizures of approximately 18,300 illegal or unregulated weight loss and diabetes medications entering the UK between 2024 and mid-2025 reflect the intersection of global demand, online distribution networks, and the exploitation of patients seeking accessible alternatives to regulated treatment. For patients, this means that products purchased through unofficial online channels or social media may have entered the UK supply chain illegally, with no quality assurance, no verified composition, and no clinical accountability attached to them. The risk is not limited to the product itself. supplying prescription medication without a valid prescription is illegal in the UK. While the legal position for individual buyers is less clear-cut, purchasing through unregulated channels removes all clinical and consumer protections and may constitute an offence depending on the specific circumstances.
Price is one of the most reliable indicators that a product is not legitimate. The wholesale cost of licensed GLP-1 medications means that any price significantly below the established private market rate should raise immediate concern. Legitimate pharmacies cannot legally price below a level consistent with procuring genuine, licensed medication. A seller offering dramatically lower prices is almost certainly not supplying the genuine product. Check for GPhC registration, a mandatory consultation process, and a verifiable physical address. If any of these are absent, do not proceed.
Weight management on the NHS remains a genuinely valuable pathway for patients who can access it. Private online pharmacies, registered with the GPhC and operating with proper clinical governance, offer a legitimate, fast, and equally safe alternative for patients who cannot. Both options involve proper clinical assessment, licensed medication, and ongoing prescriber oversight. Neither involves cutting corners with your health.
The only route that should never be considered is the unregulated one. If you have questions about which option is right for your circumstances, contact our prescribing team directly, or complete our free online consultation today.
Not sure which route is right for you?
Contact us with any questions, or start your free online consultation today.
This article was written by Pharmacy Mentor and clinically reviewed by Mohammed Ismail Lakhi, MPharm, MRPharm, Superintendent Pharmacist and Owner at The Care Pharmacy. Mohammed is registered with the General Pharmaceutical Council (GPhC registration number 2072815) and leads clinical governance across the pharmacy’s weight management services.
Last reviewed: June 2026
Disclaimer: This article is for general information only and is not a substitute for individual medical advice. Always consult a qualified prescriber before starting any prescription weight loss treatment.
Medically reviewed by
Superintendent Pharmacist
Starting a new prescription medication always comes with questions. When that medication is as clinically potent as Mounjaro (tirzepatide), those questions tend to centre on one thing above all else: the side effects. What will they feel like? When will they start? And, perhaps most importantly, how long do Mounjaro side effects last? This guide […]
Starting Mounjaro is one thing. Getting the most from it is another. The clinical evidence for tirzepatide is compelling, but the patients who achieve the best outcomes are not simply those who inject once a week and hope for the best. They are the patients who understand how the medication works, adapt their habits to […]
Search for Wegovy before and after online and you will find an overwhelming volume of content: dramatic transformation photographs, monthly progress videos, and side-by-side comparisons shared across Instagram, TikTok, and Facebook. Some of this content is genuine. Much of it is misleading. And some of it is actively dangerous, not because of what it shows, […]
If you are considering starting a weight loss medication, or you have already begun treatment and want to know what to expect, one of the most common questions is: How much weight can you lose in a month? The answer is not a single number. It depends on the medication, your starting weight, your lifestyle, […]
If you are considering weight loss medication, one of the first things a prescriber will look at is your BMI. But what is my BMI exactly, how is it calculated, and why does it carry so much weight in clinical decisions? Understanding the answer can help you know where you stand before you begin. Get […]
If you have heard about Mounjaro and wondered whether you can get it through the NHS, you are not alone. It is one of the most common questions our prescribing team receives. The short answer is: for most people, access through the NHS remains extremely limited for now. Here is everything you need to know, […]
